NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/26/2024
Back to search
Official data from USPTO
SYROS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
11/26/2024
Trademark type
Combined
Nice classes
5, 42
Filing date
12/24/2016
Registration date
02/13/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
11/26/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/15/2017
First use in commerce
11/15/2017
Drawing code
3
Owner type
03
Owner location
Cambridge, MA
Examiner
BELL, MARLENE D
Current location
Historical data usage
Mark description
The mark consists of the stylized term "SYROS" and design. The design consists of shaded circles of varying sizes that form an incomplete infinity symbol and the multi-circle loop forms the letter "O" in the term "SYROS". Dots extend above the letters "Y" and "R" and dots partially extend below the letter "R".
Holders and representatives
Holders
Syros Pharmaceuticals, Inc
Representatives
Nathan T. Harris LANDO & ANASTASI, LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations and compounds for use in the treatment of cancer; pharmaceutical preparations and compounds for inhibition of transcriptional regulators
Class 42
consulting services in the field of pharmaceutical research and development; research and development of pharmaceuticals and compounds for the treatment of cancer; research and development of pharmaceuticals and compounds for inhibition of transcriptional regulators; research and development of pharmaceutical preparations and medicines for others
Publications
History of USPTO decisions and trademark events.
29 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/26/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/26/2024
E815
TEAS SECTION 8 & 15 RECEIVED
06/14/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/17/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/17/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/17/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/17/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/17/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/15/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
02/13/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
01/10/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/09/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/19/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/18/2017
IUAF
USE AMENDMENT FILED
12/05/2017
EISU
TEAS STATEMENT OF USE RECEIVED
12/05/2017
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/25/2017
PUBO
PUBLISHED FOR OPPOSITION
05/30/2017
NPUB
NOTICE OF PUBLICATION
05/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/31/2017
CNEA
EXAMINER'S AMENDMENT MAILED
03/30/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
03/30/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/30/2017
DOCK
ASSIGNED TO EXAMINER
03/23/2017
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
01/10/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2017
NWAP
NEW APPLICATION ENTERED
12/28/2016
Continuous trademark protection
Get notified about every new filing that threatens SYROS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.